SCIENTURE HOLDINGS, INC. Operating Expenses
SCIENTURE HOLDINGS, INC. (SCNX) reported Operating Expenses of $3.04 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. operating expenses for the quarter ending 2026-06-30 was $3.04M, a 41.15% decline year-over-year.
- SCIENTURE HOLDINGS, INC. operating expenses for the quarter ending 2026-03-31 was $3.56M, a 0.24% decline year-over-year.
- SCIENTURE HOLDINGS, INC. operating expenses for the quarter ending 2025-12-31 was $29.26M, a 593.71% increase year-over-year.
- SCIENTURE HOLDINGS, INC. operating expenses for the quarter ending 2025-09-30 was $4.94M, a 40.96% increase year-over-year.
- SCIENTURE HOLDINGS, INC. operating expenses for fiscal 2025 was $42.92M, a 191.85% increase from fiscal 2024.
- SCIENTURE HOLDINGS, INC. operating expenses for fiscal 2024 was $14.71M, a 230.83% increase from fiscal 2023.
- SCIENTURE HOLDINGS, INC. operating expenses for fiscal 2023 was $4.45M, a 47.30% decline from fiscal 2022.
- SCIENTURE HOLDINGS, INC. operating expenses for fiscal 2022 was $8.44M, a 15.97% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.04M 10-Q · filed 2026-08-13 | $6.60M 10-Q · filed 2026-08-13 | $35.86M derived: sum of 3 quarters · filed 2026-08-13 | $40.79M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $3.56M 10-Q · filed 2026-05-15 | $32.82M derived: sum of 2 quarters · filed 2026-05-15 | $37.76M derived: sum of 3 quarters · filed 2026-05-15 | $42.91M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $29.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $34.19M derived: sum of 2 quarters · filed 2026-03-30 | $39.35M derived: sum of 3 quarters · filed 2026-08-13 | $42.92M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $4.94M 10-Q · filed 2025-11-12 | $10.09M derived: sum of 2 quarters · filed 2026-08-13 | $13.67M 10-Q · filed 2025-11-12 | $17.88M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $5.16M 10-Q · filed 2026-08-13 | $8.73M 10-Q · filed 2026-08-13 | $12.95M derived: sum of 3 quarters · filed 2026-08-13 | $16.45M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $3.57M 10-Q · filed 2026-05-15 | $7.79M derived: sum of 2 quarters · filed 2026-05-15 | $11.29M derived: sum of 3 quarters · filed 2026-05-15 | $12.79M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $7.72M derived: sum of 2 quarters · filed 2026-03-30 | $9.21M derived: sum of 3 quarters · filed 2026-03-30 | $14.71M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $3.50M 10-Q · filed 2025-11-12 | $5.00M derived: sum of 2 quarters · filed 2025-11-12 | $10.49M 10-Q · filed 2025-11-12 | $12.63M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $1.49M 10-Q · filed 2025-08-12 | $6.99M 10-Q · filed 2025-08-12 | $9.13M derived: sum of 3 quarters · filed 2025-08-12 | $9.93M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $5.49M 10-Q · filed 2025-05-12 | $5.50M 10-Q · filed 2024-06-26 | $7.63M derived: sum of 2 quarters · filed 2025-05-12 | $8.43M derived: sum of 3 quarters · filed 2025-05-12 | $9.10M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $2.94M derived: sum of 2 quarters · filed 2025-03-26 | $3.61M derived: sum of 3 quarters · filed 2025-03-26 | $4.45M 10-K · filed 2025-03-26 | $9.86M 10-K · filed 2024-04-22 | |||
| 2023-09-30 | $801.27K 10-Q · filed 2024-11-06 | $2.55M 10-Q · filed 2024-01-16 | $1.47M derived: sum of 2 quarters · filed 2024-11-06 | $2.31M 10-Q · filed 2024-11-06 | $5.92M 10-Q · filed 2024-01-16 | $4.93M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $666.92K 10-Q · filed 2024-08-09 | $1.99M 10-Q · filed 2023-08-18 | $1.50M 10-Q · filed 2024-08-09 | $3.89M 10-Q · filed 2023-08-18 | $4.13M derived: sum of 3 quarters · filed 2024-08-09 | $5.72M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $879.31K 10-Q · filed 2024-06-26 | $1.90M 10-Q · filed 2023-05-15 | $3.46M derived: sum of 2 quarters · filed 2024-06-26 | $5.05M derived: sum of 3 quarters · filed 2024-06-26 | $7.32M derived: sum of 4 quarters · filed 2024-06-26 | |||
| 2022-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $4.17M derived: sum of 2 quarters · filed 2024-04-22 | $6.44M derived: sum of 3 quarters · filed 2024-04-22 | $8.44M 10-K · filed 2024-04-22 | $9.88M 10-K · filed 2023-03-27 | |||
| 2022-09-30 | $1.59M 10-Q · filed 2024-01-16 | $1.81M 10-Q · filed 2022-11-07 | $3.87M derived: sum of 2 quarters · filed 2024-01-16 | $5.86M 10-Q · filed 2024-01-16 | $6.39M 10-Q · filed 2022-11-07 | $8.19M derived: sum of 4 quarters · filed 2024-01-16 | ||
| 2022-06-30 | $2.27M 10-Q · filed 2023-08-18 | $4.58M 10-Q · filed 2023-08-18 | $6.60M derived: sum of 3 quarters · filed 2023-08-18 | $9.18M derived: sum of 4 quarters · filed 2023-08-18 | ||||
| 2022-03-31 | $2.30M 10-Q · filed 2023-05-15 | $4.33M derived: sum of 2 quarters · filed 2023-05-15 | $6.90M derived: sum of 3 quarters · filed 2023-05-15 | $10.31M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $4.60M derived: sum of 2 quarters · filed 2023-03-27 | $8.01M derived: sum of 3 quarters · filed 2023-03-27 | $10.04M 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | $2.58M 10-Q · filed 2022-11-07 | $5.99M derived: sum of 2 quarters · filed 2022-11-07 | $8.02M 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | $3.41M 10-Q · filed 2022-07-25 | $5.44M 10-Q · filed 2022-07-25 | ||||||
| 2021-03-31 | $2.03M 10-Q · filed 2022-05-09 | |||||||
| 2020-12-31 | $8.21M 10-K · filed 2022-03-28 | |||||||
| 2019-12-31 | $4.75M 10-K · filed 2021-03-29 | |||||||
| 2018-12-31 | $3.47M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |